1958 Results for "

highly selective

" in MedChemExpress (MCE) Product Catalog:
Products (1958)

1958 Results for "highly selective" in MCE Product Catalog:

259
259 Publications Verification
Cat. No.: HY-15531
CAS No.: 1257044-40-8
Purity:  99.95%
Synonyms: ABT-199; GDC-0199; RG7601
Target:  

Bcl-2 Family Autophagy

Research Areas:  

Cancer

Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy .
loading...
    loading...
202
202 Cited Publications
Cat. No.: HY-50846
CAS No.: 942183-80-4
Target:  

ERK

Research Areas:  

Neurological Disease Cancer

SCH772984 is a highly selective and ATP-competitive ERK inhibitor, with IC50s of 4 and 1 nM for ERK1 and ERK2, respectively. SCH772984 has antitumor activity in MAPK inhibitor-naive and MAPK inhibitor-resistant cells containing BRAF or RAS mutations .
loading...
    loading...
138
138 Cited Publications
Cat. No.: HY-13434
CAS No.: 56092-81-0
Purity:  99.27%
Synonyms: SQ23377
Ionomycin (SQ23377) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin (SQ23377) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin also induces the activation of protein kinase C (PKC) .
loading...
    loading...
138
138 Cited Publications
Cat. No.: HY-13434A
CAS No.: 56092-82-1
Purity:  98.02%
Synonyms: SQ23377 calcium
Ionomycin calcium (SQ23377 calcium) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin calcium (SQ23377 calcium) is highly specific for divalent cations (Ca>Mg>Sr=Ba). Ionomycin (SQ23377) promotes apoptosis. Ionomycin calcium (SQ23377 calcium) also induces the activation of protein kinase C (PKC) .
loading...
    loading...
116
116 Cited Publications
Cat. No.: HY-134836
CAS No.: 2499663-01-1
Purity:  99.86%
Target:  

Apoptosis METTL3

Research Areas:  

Cancer

STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be used for the research of acute myeloid leukaemia (AML) .
loading...
    loading...
105
105 Cited Publications
Cat. No.: HY-13470
CAS No.: 1346574-57-9
Purity:  99.76%
Synonyms: GSK2816126A
Research Areas:  

Cancer

GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM .
loading...
    loading...
101
101 Cited Publications
Cat. No.: HY-114153A
Purity:  99.88%
Target:  

c-Fms

PLX5622 hemifumarate is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM; Ki=5.9 nM). PLX5622 hemifumarate allows for extended and specific microglial elimination, preceding and during pathology development. PLX5622 hemifumarate demonstrates desirable PK properties in varies animals .
loading...
    loading...
101
101 Cited Publications
Cat. No.: HY-114153
CAS No.: 1303420-67-8
Purity:  99.79%
Target:  

c-Fms

PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM; Ki=5.9 nM). PLX5622 allows for extended and specific microglial cells elimination, preceding and during pathology development. PLX5622 is an ideal choose for microglia function research in healthy or diseased states. PLX5622 has been verified by MedChemExpress, which demonstrates desirable microglia depletion efficiency in mice. PLX5622 is predominantly administered via ad libitum diets with a dose of 1200 ppm .
loading...
    loading...
73
73 Cited Publications
Cat. No.: HY-15392
CAS No.: 1273579-40-0
Purity:  99.42%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 is a highly potent and selective ROCK inhibitor. Chroman 1 is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
73
73 Cited Publications
Cat. No.: HY-15392A
Purity:  99.11%
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

Chroman 1 dihydrochloride is a highly potent and selective ROCK inhibitor. Chroman 1 dihydrochloride is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM). Chroman 1 dihydrochloride also has inhibitory activity against MRCK, with an IC50 of 150 nM .
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-15186A
CAS No.: 1396257-94-5
Purity:  99.09%
Synonyms: GDC-0068 dihydrochloride; RG-7440 dihydrochloride
Target:  

Organoid Akt

Research Areas:  

Cancer

Ipatasertib dihydrochloride (GDC-0068 dihydrochloride) is a highly selective and ATP-competitive pan-Akt inhibitor with IC50s of 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively.
loading...
    loading...
69
69 Cited Publications
Cat. No.: HY-15186
CAS No.: 1001264-89-6
Purity:  99.79%
Synonyms: GDC-0068; RG7440
Target:  

Organoid Akt Apoptosis

Research Areas:  

Cancer

Ipatasertib (GDC-0068) is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models .
loading...
    loading...
67
67 Cited Publications
Cat. No.: HY-12016
CAS No.: 587871-26-9
Purity:  99.92%
Target:  

ATM/ATR Autophagy

Research Areas:  

Cancer

KU-55933 is a potent ATM inhibitor with an IC50 and Ki of 12.9 and 2.2 nM, respectively, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.
loading...
    loading...
60
60 Cited Publications
Cat. No.: HY-50855B
CAS No.: 1309357-15-0
Synonyms: CX-4945 sodium salt
Target:  

Casein Kinase Autophagy

Research Areas:  

Cancer

Silmitasertib sodium salt is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
loading...
    loading...
60
60 Cited Publications
Cat. No.: HY-50855
CAS No.: 1009820-21-6
Synonyms: CX-4945
Target:  

Casein Kinase Autophagy

Research Areas:  

Cancer

Silmitasertib (CX-4945) is an orally bioavailable, highly selective and potent CK2 inhibitor, with IC50 values of 1 nM against CK2α and CK2α'.
loading...
    loading...
58
58 Cited Publications
Cat. No.: HY-13909
CAS No.: 1357389-11-7
Purity:  99.81%
Target:  

HDAC

Research Areas:  

Cancer

RGFP966 is a highly selective HDAC3 inhibitor with an IC50 of 80 nM and shows no inhibition to other HDACs at concentrations up to 15 μM. RGFP966 can penetrate the blood brain barrier (BBB).
loading...
    loading...
57
57 Cited Publications
Cat. No.: HY-13026
CAS No.: 870281-82-6
Purity:  99.69%
Synonyms: CAL-101; GS-1101
Target:  

PI3K Autophagy

Research Areas:  

Cancer

Idelalisib (CAL-101; GS-1101) is a highly selective and orally bioavailable p110δ inhibitor with an IC50 of 2.5 nM, showing 40- to 300-fold selectivity for p110δ over other PI3K class I enzymes.
loading...
    loading...
54
54 Cited Publications
Cat. No.: HY-15816A
CAS No.: 1956366-10-1
Purity:  99.89%
Synonyms: BVD-523 hydrochloride; VRT752271 hydrochloride
Target:  

ERK

Research Areas:  

Cancer

Ulixertinib hydrochloride (BVD-523 hydrochloride) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib hydrochloride inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line .
loading...
    loading...
54
54 Cited Publications
Cat. No.: HY-15816
CAS No.: 869886-67-9
Purity:  99.95%
Synonyms: BVD-523; VRT752271
Target:  

ERK

Research Areas:  

Cancer

Ulixertinib (BVD-523; VRT752271) is a potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases, with an IC50 of <0.3 nM against ERK2. Ulixertinib (BVD-523; VRT752271) inhibits the phosphorylated ERK2 (pERK) and downstream kinase RSK (pRSK) in an A375 melanoma cell line .
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-13951
CAS No.: 72795-01-8
Purity:  99.74%
Synonyms: ICI-118551 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease Endocrinology

Zenidolol (ICI-118551) hydrochloride is a highly selective β2 adrenergic receptor antagonist, with Kis of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.
loading...
    loading...